Shridharmurthy, Divya
Khan, Sara
Lapane, Kate L.
Yi, Esther
Kay, Jonathan
Liu, Shao-Hsien https://orcid.org/0000-0003-4317-4986
Funding for this research was provided by:
Novartis Pharmaceuticals Corporation
National Center for Advancing Translational Sciences (UL1TR000161)
Article History
Received: 17 November 2021
Revised: 5 January 2022
Accepted: 15 January 2022
First Online: 21 January 2022
Declarations
:
: The study was approved by the UMass Chan Medical School Institutional Review Board. All participants provided informed consent. Authors Sara Khan, Divya Shridharmurthy, Kate L. Lapane PhD, Jonathan Kay, MD, and Shao-Hsien Liu, MPH, PhD, have no competing interests directly related to this study.
: Not applicable.
: Dr. Yi is an employee of Novartis. The other authors have disclosed no conflicts of interest.